Calcified nodule as a cause of myocardial infarction with non- obstructive coronary artery disease

Introduction: In patients presenting with myocardial infarction (MI), angiography most often reveals obstructive coronary artery disease (CAD) but 5–20% of patients with MI have non-obstructive CAD (MINOCA) at angiography. Calcified nodule has been identified as a cause of MI with obstructive CAD but to date has not been reported as a cause of MINOCA. Intravascular ultrasound (IVUS) may find an underlying cause of MINOCA but has limited sensitivity for calcified nodule. We report a case of calcified nodule in a patient with MINOCA diagnosed by optical coherence tomography (OCT). Case Report: The patient was a 60-year-old male former smoker with CAD risk factors who presented with one hour of mid-sternal chest pain. Troponin peaked at 1.28 ng/ ml. Electrocardiogram of the patient was normal. Coronary angiography showed minimal luminal irregularities. The patient underwent intracoronary OCT. On OCT, thrombus was identified overlying a calcified plaque with protrusion into the right coronary artery lumen. The appearance was characteristic of calcified nodule. Cardiac MRI scan showed hypokinesis in the basal inferoseptal and basal anterior walls without late gadolinium enhancement. The patient was treated with dual antiplatelet therapy (aspirin and clopidogrel) and a high intensity statin. Conclusion: These combined clinical, OCT and CMR findings confirm that calcified nodule is a cause of MINOCA and underscore the utility of intracoronary imaging to determine the pathophysiology of MINOCA. Even without intracoronary imaging, plaque disruption (e.g. plaque rupture, erosion, or calcified nodule) should be considered in cases of MINOCA based on prevalence of at least 35–40% in prior studies. (This page in not part of the published article.) International Journal of Case Reports and Images, Vol. 7 No. 6, June 2016. ISSN – [0976-3198] Int J Case Rep Images 2016;7(6):388–391. www.ijcasereportsandimages.com Dugan et al. 388 CASE REPORT OPEN ACCESS Calcified nodule as a cause of myocardial infarction with non-obstructive coronary artery disease Kaitlyn E. Dugan, Akiko Maehara, Raymond Y. Kwong, Asha M. Mahajan, Harmony R. Reynolds

protrusion into the right coronary artery lumen. the appearance was characteristic of calcified nodule. cardiac MrI scan showed hypokinesis in the basal inferoseptal and basal anterior walls without late gadolinium enhancement. the patient was treated with dual antiplatelet therapy (aspirin and clopidogrel) and a high intensity statin. conclusion: these combined clinical, Oct and cMr findings confirm that calcified nodule is a cause of MINOcA and underscore the utility of intracoronary imaging to determine the pathophysiology of MINOcA. Even without intracoronary imaging, plaque disruption (e.g. plaque rupture, erosion, or calcified nodule) should be considered in cases of MINOcA based on prevalence of at least 35-40% in prior studies. often reveals obstructive coronary artery disease (CAD) (defined as angiographic stenosis ≥50% in any major epicardial vessel). However, 5-20% of patients presenting with myocardial infarction (MI) have no obstructive CAD at angiography [1]. Myocardial infraction with nonobstructive CAD (MINOCA) is a common problem, with estimated incidence of 54,000-187,000 people annually in the US [1,2]. Angiography alone does not identify the underlying etiology of MINOCA. Prior studies using intravascular ultrasound (IVUS) have identified plaque disruption (rupture or ulceration) in 35-40% of these patients [3,4]. However, IVUS has limited sensitivity for other types of plaque disruption such as plaque erosion and calcified nodule. A newer imaging technology, optical coherence tomography (OCT), has emerged to better characterize plaque morphology. Optical coherence tomography uses near-infrared light to acquire images. OCT has the advantage of far improved surface resolution and enhanced detail of the luminal surface of the coronary artery, though the depth of the vessel imaged may be less than with IVUS [5,6]. As such OCT can provide insight into the mechanism of MI, particularly when angiography reveals non-obstructive CAD.
The calcified nodule has been identified as a potentially vulnerable plaque. It is defined based on OCT imaging criteria as a signal-poor region with poorly delineated borders which protrudes into the arterial lumen [7]. It is typically associated with thrombus. Thrombus on OCT is recognized based on protruding and often irregular surfaces associated with backscatter. The nodular calcification distinguishes it from other forms of plaque. The underlying pathophysiology of MI with calcified nodule is thought to be related to an abnormal endothelial interface which induces thrombus formation. A recent OCT analysis of patients presenting with ACS and obstructive CAD found that patients with calcified nodules tended to present with non-ST elevation myocardial infarction, were older, and had higher rates of hypertension and chronic renal disease [7]. To date, calcified nodule has not been reported as a cause of MINOCA. Herein we report a case of a calcified nodule in a patient with MINOCA.

cAsE rEPOrt
The patient was a 60-year-old male former smoker with hyperlipidemia, hypertension, paroxysmal atrial fibrillation, heart failure with preserved ejection fraction, Factor V Leiden deficiency, and previously treated prostate cancer who presented with one hour of mid-sternal chest pain, the first such episode in his life. Troponin was 0.576 on admission and peaked at 1.280 (upper limit of normal is 0.04 ng/ml). The EKG was normal. He was treated with aspirin, clopidogrel, unfractionated heparin, and a highdose statin and was referred for cardiac catheterization.
At the time of coronary angiography, the left anterior descending (LAD) artery, left circumflex (LCx) artery, and right coronary artery (RCA) had minimal luminal irregularities ( Figure 1). As part of an ongoing research study for which the patient had provided informed consent (NCT02270359), he underwent optical coherence tomography optical coherence tomography of the left and right coronary arteries. Optical coherence tomography images were reviewed by an experienced observer (A.M.) who was blinded to all clinical information, including angiographic findings, at the time of review. As shown in Figure 2, thrombus was identified overlying a calcified plaque with protrusion into the lumen of the right coronary artery. Although thrombus was present in the  lumen of the artery, it did not obstruct flow, nor was there evidence of a stenosis >50% on angiography as previously mentioned. The appearance was characteristic of calcified nodule.
Cardiac MRI scan was also performed per protocol and showed hypokinesis in the basal inferoseptal and basal anterior walls. Late gadolinium enhancement imaging did not show evidence of significant myocardial necrosis.
The patient was continued on dual antiplatelet therapy and a high intensity statin. Intracoronary OCT, which was high imaging resolution, made the diagnosis in this case. Based on the identification of an underlying etiology involving thrombosis on the OCT, the patient will be treated with dual antiplatelet therapy for one year followed by lifelong aspirin in addition to a high intensity statin.

DIscUssION
These findings confirm that calcified nodule is a cause of mycardial infraction (MI) with nonobstructive CAD (MINOCA) and underscore the utility of intracoronary imaging to determine the mechanism of MI when angiography shows non-obstructive CAD. Intracoronary imaging and cardiac MRI scan may provide complementary supporting evidence of the underlying diagnosis in patients with MINOCA. Even in the absence of intracoronary imaging, plaque disruption should be consistent as a cause of MINOCA (i.e., plaque rupture, erosion, or calcified nodule) based on prevalence of at least 35-40% in prior studies. Treatment of MI due to calcified nodule and other forms of plaque disruption in MINOCA should be considered with guideline-recommended treatment of NSTEMI or STEMI, according to the clinical presentation.

Edorium Journals: An introduction
Edorium Journals Team

But why should you publish with Edorium Journals?
In less than 10 words -we give you what no one does.

Vision of being the best
We have the vision of making our journals the best and the most authoritative journals in their respective specialties. We are working towards this goal every day of every week of every month of every year.

Exceptional services
We care for you, your work and your time. Our efficient, personalized and courteous services are a testimony to this.

Editorial Review
All manuscripts submitted to Edorium Journals undergo pre-processing review, first editorial review, peer review, second editorial review and finally third editorial review.

Peer Review
All manuscripts submitted to Edorium Journals undergo anonymous, double-blind, external peer review.

Early View version
Early View version of your manuscript will be published in the journal within 72 hours of final acceptance.

Manuscript status
From submission to publication of your article you will get regular updates (minimum six times) about status of your manuscripts directly in your email.

Favored Author program
One email is all it takes to become our favored author. You will not only get fee waivers but also get information and insights about scholarly publishing.

Institutional Membership program
Join our Institutional Memberships program and help scholars from your institute make their research accessible to all and save thousands of dollars in fees make their research accessible to all.

Our presence
We have some of the best designed publication formats. Our websites are very user friendly and enable you to do your work very easily with no hassle. Something more...
We request you to have a look at our website to know more about us and our services.
We welcome you to interact with us, share with us, join us and of course publish with us.

Invitation for article submission
We sincerely invite you to submit your valuable research for publication to Edorium Journals.

Six weeks
You will get first decision on your manuscript within six weeks (42 days) of submission. If we fail to honor this by even one day, we will publish your manuscript free of charge.*

Four weeks
After we receive page proofs, your manuscript will be published in the journal within four weeks (31 days). If we fail to honor this by even one day, we will publish your manuscript free of charge and refund you the full article publication charges you paid for your manuscript.* This page is not a part of the published article. This page is an introduction to Edorium Journals and the publication services. * Terms and condition apply. Please see Edorium Journals website for more information.